Finacea and Oxycodone drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Finacea (azelaic acid) and Oxycodone (oxycodone hydrochloride). Common drug interactions include inflammation among females and diarrhoea among males.

The phase IV clinical study analyzes what interactions people have when they take Finacea and Oxycodone. It is created by eHealthMe based on reports of 25 people who take the same drugs from the FDA, and is updated regularly.

What is Finacea?

Finacea has active ingredients of azelaic acid. It is often used in rosacea. eHealthMe is studying from 2,097 Finacea users. Check the latest studies of Finacea.

What is Oxycodone?

Oxycodone has active ingredients of oxycodone hydrochloride. It is often used in pain. eHealthMe is studying from 162,592 Oxycodone users. Check the latest studies of Oxycodone.



On Jul, 12, 2026

25 people who take Finacea and Oxycodone together, and have interactions are studied.

Finacea and Oxycodone drug interactions.

What are the common drug interactions of Finacea and Oxycodone, by gender? *:

female:

  1. Inflammation
  2. Live birth
  3. Urticaria (rash of round, red welts on the skin that itch intensely)
  4. Back injury
  5. Depression
  6. Drug ineffective
  7. Abdominal pain upper
  8. Anti-cyclic citrullinated peptide antibody positive
  9. Arthralgia (joint pain)
  10. Asthenia (weakness)

male:

  1. Diarrhoea
  2. Arthritis (form of joint disorder that involves inflammation of one or more joints)
  3. Rhinorrhoea (watery mucus discharge from the nose)
  4. Squamous cell carcinoma (a cancer of a kind of epithelial cell)
  5. Weight decreased
  6. Back disorder
  7. Brain injury
  8. Chronic kidney disease
  9. Constipation
  10. Musculoskeletal discomfort (discomfort in the body's muscles, joints, tendons, ligaments and nerves)

What are the common drug interactions of Finacea and Oxycodone, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
  2. Pulmonary embolism (blockage of the main artery of the lung)

40-49:

  1. Injury
  2. Joint range of motion decreased (disease of joint movement)
  3. Joint swelling
  4. Lip dry
  5. Memory impairment
  6. Mobility decreased (ability to move is reduced)
  7. Nail disorder (disease of nail)
  8. Pericarditis (inflammation of the pericardium)
  9. Rheumatic fever (an inflammatory disease that occurs following a streptococcus pyogenes infection)
  10. Swelling

50-59:

n/a

60+:

  1. Ankle fracture
  2. Anxiety
  3. Depression
  4. Diarrhoea
  5. Dysstasia (difficulty in standing)
  6. Fall
  7. Foot deformity (functional disability of foot)
  8. Gallbladder disorder
  9. Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development)
  10. Malabsorption (a state arising from abnormality in absorption of food nutrients across the gastrointestinal (gi) tract)

What are the existing conditions these people have? *

  1. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 14 people, 56.00%
  2. Migraine (headache): 14 people, 56.00%
  3. Psoriasis (immune-mediated disease that affects the skin): 13 people, 52.00%
  4. Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 9 people, 36.00%
  5. Arthropathy: 5 people, 20.00%
  6. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 2 people, 8.00%
  7. Immunodeficiency Common Variable: 2 people, 8.00%
  8. Immune System Disorder: 2 people, 8.00%
  9. Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 2 people, 8.00%
  10. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 2 people, 8.00%

* Approximation only. Some reports may have incomplete information.

Do you take Finacea and Oxycodone?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Finacea and Oxycodone:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Finacea:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Oxycodone:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Finacea and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Oxycodone and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on azelaic acid and oxycodone hydrochloride (the active ingredients of Finacea and Oxycodone, respectively), and Finacea and Oxycodone (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: